Lung Cancer

Top Story

Survivors of adult-onset cancer experience increased CVD risk

Survivors of adult-onset cancer experience increased CVD risk
February 9, 2016

The risk for cardiovascular disease appeared greater among adult survivors of certain cancer subtypes, including multiple myeloma, lung cancer, non-Hodgkin’s lymphoma and breast cancer, according to the results of a retrospective study.

Further, survivors who developed cardiovascular disease (CVD) experienced poor OS, results showed.

In the Journals

Unprovoked VTE may increase risk for subsequent cancer diagnosis

February 9, 2016
Unprovoked venous thromboembolism appeared associated with a consistently high risk for subsequent cancer diagnosis, according to results of a population-based cohort…
In the Journals

Experts reveal ‘troubling’ industry-employed strategies to delay availability of generic cancer drugs

February 8, 2016
Pharmaceutical companies have employed several strategies — including reverse payment, patent settlements and “product hopping” — to prevent…
In the JournalsPerspective

ASCO: Immunotherapy is ‘Cancer Advance of the Year’

February 4, 2016
ASCO has named progress in immunotherapy for melanoma and other malignancies as the top cancer advance of the year, according to “Clinical Cancer Advances 2016…
CME

The Patient with Myelofibrosis

No commercial support for this activity.

Myelofibrosis is caused by abnormal stem cells in the bone marrow that cause the uncontrolled production of mature…
More »
Meeting News CoverageVideo

VIDEO: Novel drugs represent 'ground-breaking developments' for EGFR-mutated lung cancer

June 12, 2015
More »
Featured
CME

World Lung Updates: Immunotherapy in NSCLC

This activity is supported by an educational grant from Genentech, Inc and Merck & Co., Inc.

Globally, lung cancer is the leading cause of cancer-related deaths. Non-small cell lung cancer (NSCLC) accounts for…
More »
In the Journals

Survivors of adult-onset cancer experience increased CVD risk

February 9, 2016
The risk for cardiovascular disease appeared greater among adult survivors of certain cancer subtypes, including multiple myeloma, lung cancer…
In the Journals

Unprovoked VTE may increase risk for subsequent cancer diagnosis

February 9, 2016
Unprovoked venous thromboembolism appeared associated with a consistently high risk for subsequent cancer diagnosis, according to results of a…
In the Journals

Experts reveal ‘troubling’ industry-employed strategies to delay availability of generic cancer drugs

February 8, 2016
Pharmaceutical companies have employed several strategies — including reverse payment, patent settlements and “product hopping”…
In the JournalsPerspective

ASCO: Immunotherapy is ‘Cancer Advance of the Year’

February 4, 2016
ASCO has named progress in immunotherapy for melanoma and other malignancies as the top cancer advance of the year, according to “Clinical…
In the Journals

World Cancer Day: ‘We can’ reduce global cancer burden

February 4, 2016
Today marks the annual observation of World Cancer Day, founded by the Union for International Cancer Control to raise awareness of cancer and…

Memorial Sloan Kettering program focuses on cancer disparities among U.S. immigrants

February 1, 2016
Immigrants are considerably underserved in terms of health care in the United States. Memorial Sloan Kettering Cancer Center launched its Immigrant…
In the Journals

Quitting smoking reduces risk for breast cancer death

February 1, 2016
Breast cancer survivors who quit smoking after their diagnosis reduced their risk for death 33%, according to findings from a population-based…
In the JournalsPerspective

Neoadjuvant bevacizumab may improve resection of stage III lung cancer

January 29, 2016
The addition of bevacizumab to induction chemotherapy appeared associated with high objective response and resectability rates among patients with…
In the Journals

Bankruptcy increases risk for cancer mortality

January 28, 2016
Filing for bankruptcy protection after a cancer diagnosis appeared associated with an increased risk for death, according to the results of a…

MD Anderson Cancer Center, AbbVie announce cancer immunotherapy collaboration

January 27, 2016
The University of Texas MD Anderson Cancer Center and AbbVie have announced a three-year collaborative agreement to choose and carry out preclinical…
More Headlines »
morganatic-roan morganatic-roan